<VariationArchive VariationID="2426947" VariationName="NC_000011.9:g.(?_72004411)_(72006712_?)del" VariationType="Deletion" Accession="VCV002426947" Version="7" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1950485" VariationID="2426947">
      <GeneList>
        <Gene Symbol="CLPB" FullName="ClpB family mitochondrial disaggregase" GeneID="81570" HGNC_ID="HGNC:30664" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q13.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="72285495" stop="72434531" display_start="72285495" display_stop="72434531" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="72003468" stop="72145723" display_start="72003468" display_stop="72145723" Strand="-" />
          </Location>
          <OMIM>616254</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000011.9:g.(?_72004411)_(72006712_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q13.4</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" innerStart="72004411" innerStop="72006712" display_start="72004411" display_stop="72006712" variantLength="2302" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.(?_72004411)_(72006712_?)del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.(?_72004411)_(72006712_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000011.9:g.(?_72004411)_(72006712_?)del AND 3-methylglutaconic aciduria, type VIIB" Accession="RCV003122780" Version="4">
        <ClassifiedConditionList TraitSetID="20957">
          <ClassifiedCondition DB="MedGen" ID="C5676893">3-methylglutaconic aciduria, type VIIB</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-10-05" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="20957" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33015" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">3-methylglutaconic aciduria with cataracts, neurologic involvement and neutropenia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">3-methylglutaconic aciduria, type VIIB</ElementValue>
                <XRef ID="MONDO:0014561" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MGCA7B</ElementValue>
                <XRef Type="MIM" ID="616271" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MGCA7</ElementValue>
                <XRef Type="MIM" ID="616271" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">CLPB (caseinolytic peptidase B) deficiency is characterized by neurologic involvement and neutropenia, which can range from severe to mild. In severe CLPB deficiency, death usually occurs at a few months of age due to significant neonatal neurologic involvement (hyperekplexia or absence of voluntary movements, hypotonia or hypertonia, swallowing problems, respiratory insufficiency, and epilepsy) and severe neutropenia associated with life-threatening infections. Individuals with moderate CLPB deficiency present with neurologic abnormalities in infancy including hypotonia and feeding problems, and develop spasticity, a progressive movement disorder (ataxia, dystonia, and/or dyskinesia), epilepsy, and intellectual disability. Neutropenia is variable, but not life threatening. In those with mild CLPB deficiency there is no neurologic involvement, intellect is normal, neutropenia is mild and intermittent, and life expectancy is normal.</Attribute>
                <XRef ID="NBK396257" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17767" />
                <XRef ID="17767" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27891836</ID>
                <ID Source="BookShelf">NBK396257</ID>
              </Citation>
              <XRef ID="445038" DB="Orphanet" />
              <XRef ID="C5676893" DB="MedGen" />
              <XRef ID="MONDO:0014561" DB="MONDO" />
              <XRef Type="MIM" ID="616271" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7075922" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_030813.5_11_Deletion (exons 13-17)|MedGen:C4225393" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003795631" DateUpdated="2024-06-09" DateCreated="2023-02-13" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 13-17 of the CLPB gene, which includes the termination codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product. This variant has not been reported in the literature in individuals affected with CLPB-related conditions. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the CLPB protein in which other variant(s) (p.Tyr567Cys) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CLPB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.(?_72004411)_(72006712_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4225393" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7075922" TraitType="Disease" MappingType="XRef" MappingValue="C4225393" MappingRef="MedGen">
        <MedGen CUI="C5676893" Name="3-methylglutaconic aciduria, type VIIB" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

